AbbVie (ABBV) Gross Profit (2012 - 2026)
AbbVie (ABBV) recorded Gross Profit of $12.7 billion in Q2 2026, up 14.6% from $11.08 billion a year earlier and up 17.8% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Gross Profit (2012 - 2026) Analysis & Trends
On a TTM basis, AbbVie's Gross Profit came in at $46.02 billion as of Jun 30, 2026, up 11.2% year-over-year; for FY2025, it came in at $42.96 billion, up 8.9% from FY2024.
- Annual Gross Profit has a five-year compound annual growth rate of 7.1% (FY2020 to FY2025).
- Across earlier years, Gross Profit came in at $39.43 billion in FY2024 (+16.3%), $33.9 billion in FY2023 (-16.6%), $40.64 billion in FY2022 (+4.9%) and $38.75 billion in FY2021 (+27.4%).
- The Q2 2026 figure is the highest quarterly Gross Profit in data going back to Q1 2012.
- On a year-over-year basis, Gross Profit has increased for nine consecutive quarters, with growth averaging 16.1% over the last eight quarters.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 37.7% in Q3 2024, against a decline of 24.0% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $10.78 billion (Q1 2026), $12.07 billion (Q4 2025) and $10.47 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.70 Bn |
| Mar 31, 2026 | 10.78 Bn |
| Dec 31, 2025 | 12.07 Bn |
| Sep 30, 2025 | 10.47 Bn |
| Jun 30, 2025 | 11.08 Bn |
| Mar 31, 2025 | 9.34 Bn |
| Dec 31, 2024 | 10.71 Bn |
| Sep 30, 2024 | 10.25 Bn |
| Jun 30, 2024 | 10.26 Bn |
| Mar 31, 2024 | 8.22 Bn |
| Dec 31, 2023 | 8.60 Bn |
| Sep 30, 2023 | 7.44 Bn |
| Jun 30, 2023 | 9.63 Bn |
| Mar 31, 2023 | 8.24 Bn |
| Dec 31, 2022 | 10.95 Bn |
| Sep 30, 2022 | 9.79 Bn |
| Jun 30, 2022 | 10.41 Bn |
| Mar 31, 2022 | 9.49 Bn |
| Dec 31, 2021 | 10.57 Bn |
| Sep 30, 2021 | 9.95 Bn |
API Access
AbbVie Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();